Kurzfassung

A randomised, multi-centre, double-blind, placebo-controlled, single/multiple dose escalation phase Ib/IIa clinical trial to investigate the safety and efficacy of recombinant human soluble Fc gamma receptor IIb (SM101) for intravenous application in the treatment of patients with chronic adult Idiopathic Thrombocytopenic Purpura (ITP)